Ultragenyx Pharmaceutical, Inc. (RARE)

22.75 +0.24 (+1.07%) USD  |  NASDAQ  |  Feb 24, 16:00
23.20 +0.45 (+1.98%) After-Hours: 20:00
More

Ultragenyx Pharmaceutical Net Change in Capital Expenditures (Quarterly)

Net Change in Capital Expenditures (Quarterly) Chart

View Net Change in Capital Expenditures (Quarterly) for RARE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years

View Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (Quarterly) Benchmarks

View Net Change in Capital Expenditures (Quarterly) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Johnson & Johnson Upgrade
CorMedix, Inc. Upgrade
Insmed, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade